Osborn Williams & Donohoe’s Mesoblast MESO Stock Holding History

Osborn Williams & Donohoe’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,500	Closed	-$133K	–	315
2019 Q2	$133K	Hold	12,500	–	–	0.01%	313
2019 Q1	$133K	Hold	12,500	–	–	0.01%	378
2018 Q4	$103K	Hold	12,500	–	–	0.02%	216
2018 Q3	$204K	Hold	12,500	–	–	0.03%	221
2018 Q2	$138K	Hold	12,500	–	–	0.02%	220
2018 Q1	$145K	Hold	12,500	–	–	0.03%	221
2017 Q4	$146K	Hold	12,500	–	–	0.03%	221
2017 Q3	$137K	Hold	12,500	–	–	0.02%	217
2017 Q2	$199K	Hold	12,500	–	–	0.04%	211
2017 Q1	$225K	Hold	12,500	–	–	0.04%	202
2016 Q4	$134K	Hold	12,500	–	–	0.03%	210
2016 Q3	$108K	Hold	12,500	–	–	0.02%	219
2016 Q2	$99K	Hold	12,500	–	–	0.02%	216
2016 Q1	$241K	Hold	12,500	–	–	0.05%	194
2015 Q4	$159K	Buy	+12,500	New	+$153K	0.03%	204

Other funds holding MESO

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Osborn Williams & Donohoe's MESO Position: Q3 2019 in Review

Osborn Williams & Donohoe sold out of Mesoblast (MESO) in Q3 2019, closing a stake of 12,500 shares — an estimated $133K sold.

Osborn Williams & Donohoe first reported a position in MESO in Q4 2015 and held it in 15 quarters. The position peaked at $241K in Q1 2016. 30 funds tracked by Wall St. Rank hold MESO as of Q3 2019.

Osborn Williams & Donohoe reported no remaining Mesoblast position as of Q3 2019 after selling out during the quarter.
Osborn Williams & Donohoe sold 12,500 Mesoblast shares in Q3 2019, an estimated $133K.
Osborn Williams & Donohoe first reported a position in Mesoblast in Q4 2015 and held it in 15 quarters.
Osborn Williams & Donohoe's Mesoblast position peaked at $241K in Q1 2016.
30 funds tracked by Wall St. Rank held Mesoblast as of Q3 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q3 2019, filed 16 Oct 2019.